Marc Wilson, CFO at Crinetics Pharmaceuticals, Inc. (CRNX), sold 64,258 shares at $43.61 ($2.8M) on 2024-06-28, disclosed to the SEC on 2024-07-02.
Scheduled sale ($2.8M) by CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.61 | 32,129 | $1.4M | 50.0% |
| 2 | $43.61 | 32,129 | $1.4M | 50.0% |
| Total | $43.61 avg | 64,258 | $2.8M | 100% |
| Filing → |
| CRNX | SELL | 2024-07-17 | $1.4M | — | Filing → |
| CRNX | SELL | 2024-03-20 | $596K | — | Filing → |
| CRNX | SELL | 2024-01-04 | $355K | — | Filing → |